Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US

Authors

  • Mona Saraiya MD, MPH,

    Corresponding author
    1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
    • Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS K-55, Atlanta, GA 30341
    Search for more papers by this author
    • Fax: (770) 488-4639.

  • Faruque Ahmed PhD,

    1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
    2. Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for more papers by this author
  • Mary White ScD,

    1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for more papers by this author
  • Herschel Lawson MD,

    1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for more papers by this author
  • Elizabeth R. Unger MD, PhD,

    1. Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for more papers by this author
  • Christie Eheman PhD

    1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia
    Search for more papers by this author

  • Dr. Ahmed was formerly with the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention, Atlanta, Georgia.

    The following registries, which cover approximately 83% of the US population, contributed data to the production of this supplement: Alaska, Alabama, Arkansas, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, and Wisconsin.

    We appreciate the in–kind support from all the contributors to this supplement. We are also grateful for the guidance provided by the project steering committee members: Faruque Ahmed, Umed Ajani, Janet Bates, Apputhurai Balamuragan, Vicki Benard, Cheryll Cardinez, Vivien Chen, Glenn Copeland, Michelle Cote, Steve Coughlin, Eileen Dunne, Donatus Ekwueme, Brenda Edwards, Anna Giuliano, Brenda Hernandez, Claudia Hopehayn, Djenaba Joseph, Kris Khan, Jessica King, Sue-Min Lai, Herschel Lawson, Serban Negoita, Marsha Reichman, Tom Richards, Blythe Ryerson, Mona Saraiya, Trevor Thompson, Jasmin Tiro, Meg Watson, Hannah Weir, Mary White, Martin Whiteside, Phyllis Wingo, and Xiao-Cheng Wu. Our gratitude also goes to our team of pathologists, Diane Solomon, Beth Unger, and Mark Sherman; to editorial and graphic services at the Centers for Disease Control and Prevention, especially Fonda Martin, Ernest Martin, and Rick Hull; to Dave Stinchcomb for creating maps; to Jessica King, Trevor Thompson, and Kevin Zhang for the creation of the analytic files and for data verification; to the publication committee (Tom Richards, Mona Saraiya, Phyllis Wingo, and Meg Watson); and to the leadership of the Centers for Disease Control and Prevention's Division of Cancer Prevention and Control for support of this project (Barbara Bowman and Robert German).

    The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

  • This article is a US Government work and, as such, is in the public domain in the United States of America.

Ancillary